Fuzeon (Enfuvirtide, T-20)
| Brand Name: |
Fuzeon |
| Generic Name: |
Enfuvirtide, T-20 |
| Adult Single Dose: |
Patients weighing more than 94 lbs
(42.6 kg): 90 mg (1 mL) injected subcutaneously into the upper arm,
thigh, or abdomen (twice a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
FI |
|
|
|
The Basics
- An Overview of Fuzeon (Enfuvirtide, T-20) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Enfuvirtide (Fuzeon) (May 24, 2009)
To read PDF, click here
From AIDS InfoNet
- Fuzeon (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Patient Information About Fuzeon (Enfuvirtide, T-20) (PDF) (December 2008)
From Roche
- Characteristics of Fusion and Integrase Inhibitors, and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Fuzeon (Enfuvirtide, T-20) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Important Changes to Fuzeon Product Labeling (January 31, 2007)
From U.S. Food and Drug Administration
- Fuzeon (Enfuvirtide, T-20) Patient Product Information (PDF) (November 2006)
From Roche
- T-20 (Enfuvirtide, Fuzeon) (August 15, 2006)
From AIDS Treatment Data Network
- Fuzeon (Enfuvirtide) (May 2005)
[Archived Article]
To read PDF, click here
From The Center for AIDS
- A Guide to Fuzeon: The First Fusion Inhibitor (January 2005)
[Archived Article]
To read PDF, click here
In A Guide to Fuzeon: The First Fusion Inhibitor, from The Body
- Transcript of The Body's Live Chat on Fuzeon (T-20, Enfuvirtide) (October 25, 2004)
From The Body
- Drug Interactions: Enfuvirtide (August 2004)
[Archived Article]
From Project Inform
- Transcript of The Body's Live Chat on Fuzeon (T-20, Enfuvirtide) (June 16, 2004)
From The Body
- Treatment Forum Discusses T-20 (January/February 2004)
[Archived Article]
Answers questions such as: Why is T-20 so expensive? Can it be taken by itself, or does it always have to be part of a combination? What about side effects?.
In Survival News, from AIDS Survival Project
- Three New Drugs Approved by FDA (November/December 2003)
[Archived Article]
An overview of Fuzeon (enfuvirtide, T-20), Reyataz (atazanavir) and Emtriva (emtricitabine, FTC).
In Survival News, from AIDS Survival Project
- Fuzeon -- A Review of the First Entry Inhibitor (October 2003)
[Archived Article]
A look at how entry inhibitors and Fuzeon work.
To read PDF, click here
From The Body
- Fuzeon: The Basics (October 2003)
In Fuzeon -- A Review of the First Entry Inhibitor, from The Body
- Ten Tips on Injecting Fuzeon (October 2003)
In Fuzeon -- A Review of the First Entry Inhibitor, from The Body
- The Bottom Line on T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
[Archived Article]
Bare-bones highlights of three of this year's new HIV medications.
To read PDF, click here
In Project Inform Perspective, from Project Inform
- From Injections to Pricing: The Drawbacks of T-20 (April 2003)
[Archived Article]
In TAGline, from Treatment Action Group
- Fuzeon (Enfuvirtide, T-20) Injection Instructions (PDF) (March 2003)
From Roche
- Fuzeon (T-20) Approved in the U.S. (March 13, 2003)
[Archived Article]
First drug in a new class of HIV/AIDS treatments for HIV-infected adults and children with advanced HIV infection.
From U.S. Food and Drug Administration
- New AIDS Drug Price Spurs Some Questions (March 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Long Path to Approval (March 2003)
[Archived Article]
A look back at Fuzeon's road from laboratory to pharmacy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Entry Inhibitors: T-20 (Winter 2002/2003)
[Archived Article]
In ACRIA Update, from AIDS Community Research Initiative of America
- What's Taking T-20 So Long? (April 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
First Person
- Beatriz Diaz: From Silence to Success (January 2005)
Beatriz Diaz, 49, learned the hard way that loving yourself is critical to committing to HIV treatment.
In A Guide to Fuzeon: The First Fusion Inhibitor, from The Body
- Greg Braxton: A Long Journey to Recovery (January 2005)
With a 27-year history of drinking, using drugs and sleeping with hundreds of women, Greg Braxton's AIDS diagnosis in 1994 came as no surprise.
In A Guide to Fuzeon: The First Fusion Inhibitor, from The Body
- Positive Empowerment: I Get Blessings, I Get Lesson (July/August 2003)
[Archived Article]
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- The Constant Survival Battle and T-20 (Winter 2002/2003)
All of Matt Sharp's other meds had failed; then it was T-20's turn.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
- A T-20 Diary (March 2002)
Fred Gormley's first few days as part of the drug's clinical trial.
In GMHC Treatment Issues, from Gay Men's Health Crisis
|
|
Advertisement
|
E-Mail
Glossary
Share
